Download original image
Fig. 4.
Forest plot comparing proton pump inhibitor (PPI) plus prokinetics and PPI monotherapy in patients with gastroesophageal reflux disease in term of symptom improvement, subgrouped by region of study.
J Neurogastroenterol Motil 2021;27:165~175
https://doi.org/10.5056/jnm20161
© J Neurogastroenterol Motil